| Biomarker ID | 1883 |
| PMID | 30623593 |
| Year | 2018 |
| Biomarker | Complement component C8 alpha chain; Apolipoprotein Aâ€I; Plasminogen; Complement component C7;Isoform 2 of Interâ€alphaâ€trypsin inhibitor heavy chain H4;Interâ€alphaâ€trypsin inhibitor heavy chain H1; Complement C1s subcomponent; Ig heavy chain Vâ€III region BRO; Ig gammaâ€2 chain C region; Ig gammaâ€3 chain C region; |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Decreased in Progression Free Survival |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer in African American Men Vs Normal African American Men |
| Type of Biomarker | Diagnostic |
| Cohort | Serum samples from African American and Caucasian PCa patients and matched healthy donors were collected after patients’ consents |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | mass spectrometry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |